| 'We will not sell Piramal Healthcare' | 24-OCT-09 |
|
| Nandini Piramal, heir apparent to the Piramal business empire as the elder child of Ajay Piramal and Swati Piramal, became the executive director of Piramal Healthcare in April this year. A 29-year-old graduate from Hertford College of Oxford University, with an MBA from the Stanford Graduate School of Business, she joined the firm in 2006 as a General Manager (Strategic Marketing) and has been closely associated with the company's overseas subsidiaries in US and Canada. |
|
|
|
| Piramal Healthcare gains on Q2 net jump | 23-OCT-09 |
|
| The stock extended gains and touched a high of Rs 400 - up 9%. It finally settled with a 7% gain at Rs 391. The counter witnessed trades of 431,749 shares on the BSE today. |
|
|
|
| Piramal Healthcare standalone Q2 net up 64% at Rs 114 cr | 22-OCT-09 |
|
| Piramal Healthcare, part of the Piramal group, has posted a rise of 64.4 per cent in its net profit at Rs 114.22 crore on the standalone basis for the quarter ended 30 September compared with Rs 69.44 crore posted in the corresponding quarter last year. The company's total income for the quarter grew to Rs 711.59 crore from Rs 636.9 crore, up 11.73 per cent. |
|
|
|
| 'We don't have space for more partnerships' | 14-OCT-09 |
|
| Piramal Healthcare Ltd (formerly Nicholas Piramal) — the country’s fourth-largest drug company — has been focusing on international partnerships and collaborations instead of following the high-risk route of patent challenges to grow revenues. The model has proved successful, so much so that global pharma majors from GlaxoSmithKline to Sanofi-Aventis are said to be keen on acquiring the company. |
|
|
|
| Woman power | 12-OCT-09 |
|
| Piramal Healthcare director Swati Piramal has made history by becoming the first woman chief of a national chamber of commerce. As the newly-elected president of Assocham, she’s doing her bit for woman-power. All chairpersons of around 100 working groups in Assocham are now women, and the co-chairs are all men. |
|
|
|
|
|
|
|
|
|
|
|
|
| Piramal Healthcare slips despite Q1 net rise | 23-JUL-09 |
|
| The stock ended with a loss of Rs 15 (4.5%) at Rs 318. However, volumes jumped over four-folds to 189,045 shares compared to its two-week daily trade average of 43,175 shares on the BSE today. |
|
|
|
| Piramal Healthcare Q1 net grows 45% at Rs 74 cr | 22-JUL-09 |
|
| Mumbai-based pharmaceutical company Piramal Healthcare today reported a 45 per cent increase in its net profit for the first quarter ended June 30, 2009 at Rs 74.11 crore as compared to Rs 50.94 crore recorded for the corresponding quarter a year ago. |
|
|
|
|
|
|
|
|
|
| Pharma ind seeks tax sops for R&D in drug devt | 19-JUN-09 |
|
| The domestic pharmaceutical industry has demanded exemption in income-tax and fiscal incentives in the forthcoming Budget for promoting research and development (R&D) in the field of drug discovery in India. |
|
|
|
|
|
|
| Strides Arcolab hives off research, R&D divisions | 14-APR-09 |
|
| Strides Arcolab Ltd has joined the likes of leading drug firms such as Dr Reddy’s, Piramal Healthcare and Glenmark by hiving off its research and speciality divisions to de-risk its core businesses. |
|
|
|
Content Guide
